FDA Must Do More To Ensure Drug Import Safety, Report Says

Law360, New York (April 4, 2012, 7:40 PM EDT) -- The U.S. Food and Drug Administration should team up with other developed countries to inspect drug-making facilities in countries like India and China, according to a report on the safety of drug imports commissioned by the FDA and released Wednesday.

The report, by the independent Institute of Medicine, found that developing countries lack technologically advanced systems for regulating the manufacture of pharmaceuticals and active ingredients.

The report echoed FDA concerns that many factories in the developing world go uninspected, increasing the risk that dangerous or ineffective...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.